Cardiology
Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than normal potassium ...
Nov 17, 2014
0
0